Cargando…

The taTME learning curve for mid-low rectal cancer: a single-center experience in China

PURPOSE: As transanal total mesorectal excision (taTME) is performed worldwide, the optimization of existing training and guidance programs to enhance new taTME learners’ competence in performing this procedure is warranted. This study aimed to evaluate the taTME learning curve in patients with mid-...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Fengming, Zhang, Yiqiao, Yan, Jiafu, Xu, Bowen, Wu, Guocong, Yang, Zhengyang, Sun, Liting, Zhang, Xiao, Yao, Hongwei, Zhang, Zhongtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502600/
https://www.ncbi.nlm.nih.gov/pubmed/36138427
http://dx.doi.org/10.1186/s12957-022-02763-3
_version_ 1784795746451587072
author Xu, Fengming
Zhang, Yiqiao
Yan, Jiafu
Xu, Bowen
Wu, Guocong
Yang, Zhengyang
Sun, Liting
Zhang, Xiao
Yao, Hongwei
Zhang, Zhongtao
author_facet Xu, Fengming
Zhang, Yiqiao
Yan, Jiafu
Xu, Bowen
Wu, Guocong
Yang, Zhengyang
Sun, Liting
Zhang, Xiao
Yao, Hongwei
Zhang, Zhongtao
author_sort Xu, Fengming
collection PubMed
description PURPOSE: As transanal total mesorectal excision (taTME) is performed worldwide, the optimization of existing training and guidance programs to enhance new taTME learners’ competence in performing this procedure is warranted. This study aimed to evaluate the taTME learning curve in patients with mid-low rectal cancer. METHODS: Patients who underwent taTME for mid-low rectal cancer between October 2015 and August 2021 at a single center were included. A cumulative sum (CUSUM) learning curve analysis was performed with the total operation time as the study outcome. The learning curve was analyzed using risk-adjusted CUSUM analysis, with postoperative complications and anastomotic leakage (AL) as outcomes. RESULTS: In total, 104 consecutive patients were included in this study. The CUSUM learning curve for total operative time started declining after 42 cases (309.1 ± 84.4 vs. 220.2 ± 46.4, P < 0.001). The risk-adjusted CUSUM (RA-CUSUM) learning curve for postoperative complications fluctuated in cases 44–75 and declined significantly after case 75. The RA-CUSUM learning curve for AL declined after 68 cases. CONCLUSIONS: taTME had learning curves of 42, 75, and 68 cases for total operative time, postoperative complications, and AL, respectively. A surgeon may require 42 and 75 cases to achieve “proficiency” and “mastery” in taTME procedures, respectively. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12957-022-02763-3.
format Online
Article
Text
id pubmed-9502600
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95026002022-09-24 The taTME learning curve for mid-low rectal cancer: a single-center experience in China Xu, Fengming Zhang, Yiqiao Yan, Jiafu Xu, Bowen Wu, Guocong Yang, Zhengyang Sun, Liting Zhang, Xiao Yao, Hongwei Zhang, Zhongtao World J Surg Oncol Research PURPOSE: As transanal total mesorectal excision (taTME) is performed worldwide, the optimization of existing training and guidance programs to enhance new taTME learners’ competence in performing this procedure is warranted. This study aimed to evaluate the taTME learning curve in patients with mid-low rectal cancer. METHODS: Patients who underwent taTME for mid-low rectal cancer between October 2015 and August 2021 at a single center were included. A cumulative sum (CUSUM) learning curve analysis was performed with the total operation time as the study outcome. The learning curve was analyzed using risk-adjusted CUSUM analysis, with postoperative complications and anastomotic leakage (AL) as outcomes. RESULTS: In total, 104 consecutive patients were included in this study. The CUSUM learning curve for total operative time started declining after 42 cases (309.1 ± 84.4 vs. 220.2 ± 46.4, P < 0.001). The risk-adjusted CUSUM (RA-CUSUM) learning curve for postoperative complications fluctuated in cases 44–75 and declined significantly after case 75. The RA-CUSUM learning curve for AL declined after 68 cases. CONCLUSIONS: taTME had learning curves of 42, 75, and 68 cases for total operative time, postoperative complications, and AL, respectively. A surgeon may require 42 and 75 cases to achieve “proficiency” and “mastery” in taTME procedures, respectively. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12957-022-02763-3. BioMed Central 2022-09-23 /pmc/articles/PMC9502600/ /pubmed/36138427 http://dx.doi.org/10.1186/s12957-022-02763-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Xu, Fengming
Zhang, Yiqiao
Yan, Jiafu
Xu, Bowen
Wu, Guocong
Yang, Zhengyang
Sun, Liting
Zhang, Xiao
Yao, Hongwei
Zhang, Zhongtao
The taTME learning curve for mid-low rectal cancer: a single-center experience in China
title The taTME learning curve for mid-low rectal cancer: a single-center experience in China
title_full The taTME learning curve for mid-low rectal cancer: a single-center experience in China
title_fullStr The taTME learning curve for mid-low rectal cancer: a single-center experience in China
title_full_unstemmed The taTME learning curve for mid-low rectal cancer: a single-center experience in China
title_short The taTME learning curve for mid-low rectal cancer: a single-center experience in China
title_sort tatme learning curve for mid-low rectal cancer: a single-center experience in china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502600/
https://www.ncbi.nlm.nih.gov/pubmed/36138427
http://dx.doi.org/10.1186/s12957-022-02763-3
work_keys_str_mv AT xufengming thetatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT zhangyiqiao thetatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT yanjiafu thetatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT xubowen thetatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT wuguocong thetatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT yangzhengyang thetatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT sunliting thetatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT zhangxiao thetatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT yaohongwei thetatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT zhangzhongtao thetatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT xufengming tatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT zhangyiqiao tatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT yanjiafu tatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT xubowen tatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT wuguocong tatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT yangzhengyang tatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT sunliting tatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT zhangxiao tatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT yaohongwei tatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina
AT zhangzhongtao tatmelearningcurveformidlowrectalcancerasinglecenterexperienceinchina